UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Form 10-Q
[X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended September 27, 2003
Commission file number 0-6072
EMS TECHNOLOGIES, INC.
| Georgia | 58-1035424 | |
| (State or other jurisdiction of incorporation or organization) |
(IRS Employer ID Number) |
660 Engineering Drive
Norcross, Georgia 30092
(Address of principal executive offices) (Zip Code)
(770) 263-9200
Registrants Telephone Number, Including Area Code
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes [X] No [ ]
Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act). Yes [X] No [ ]
The number of shares outstanding of each of the issuers classes of common stock, as of the close of business on November 5, 2003:
| Class | Number of Shares | |
| Common Stock, $.10 par Value | 10,691,219 |
AVAILABLE INFORMATION
EMS Technologies, Inc. makes available free of charge, on or through its website at www.ems-t.com, its annual, quarterly and current reports, and any amendments to those reports, as soon as reasonably practicable after electronically filing such reports with the Securities and Exchange Commission. Information contained on the Companys website is not part of this report.
PART I
FINANCIAL INFORMATION
ITEM 1. Financial Statements
EMS Technologies, Inc.
Consolidated Statements of Operations (Unaudited)
(in thousands, except per share data)
| Quarters Ended | Nine Months Ended | |||||||||||||||||
| Sep 27 | Sep 28 | Sep 27 | Sep 28 | |||||||||||||||
| 2003 | 2002 | 2003 | 2002 | |||||||||||||||
Net sales |
$ | 61,536 | 56,521 | 183,343 | 171,038 | |||||||||||||
Cost of sales |
39,409 | 35,711 | 116,674 | 107,498 | ||||||||||||||
Selling, general and administrative expenses |
14,304 | 12,551 | 41,531 | 39,053 | ||||||||||||||
Research and development expenses |
4,438 | 4,725 | 13,896 | 15,202 | ||||||||||||||
Operating income |
3,385 | 3,534 | 11,242 | 9,285 | ||||||||||||||
Non-operating (expense) income, net |
(9 | ) | 271 | (287 | ) | 266 | ||||||||||||
Foreign exchange (loss) gain |
(10 | ) | 677 | (422 | ) | 701 | ||||||||||||
Interest expense |
(518 | ) | (600 | ) | (1,551 | ) | (1,672 | ) | ||||||||||
Earnings from continuing operations
before income taxes |
2,848 | 3,882 | 8,982 | 8,580 | ||||||||||||||
Income tax expense |
(899 | ) | (1,122 | ) | (2,874 | ) | (3,015 | ) | ||||||||||
Earnings from continuing operations |
1,949 | 2,760 | 6,108 | 5,565 | ||||||||||||||
Discontinued operations (note 2): |
||||||||||||||||||
Gain (loss) from discontinued operations |
(25,016 | ) | (1,074 | ) | (43,755 | ) | 803 | |||||||||||
Income tax benefit |
2,476 | 280 | 3,008 | 201 | ||||||||||||||
Net earnings (loss) |
$ | (20,591 | ) | 1,966 | (34,639 | ) | 6,569 | |||||||||||
Earnings (loss) per share: |
||||||||||||||||||
Basic: |
||||||||||||||||||
From continuing operations |
$ | 0.18 | 0.25 | 0.57 | 0.53 | |||||||||||||
From discontinued operations |
(2.11 | ) | (0.07 | ) | (3.82 | ) | 0.09 | |||||||||||
Net earnings (loss) |
(1.93 | ) | 0.18 | (3.25 | ) | 0.62 | ||||||||||||
Diluted: |
||||||||||||||||||
From continuing operations |
$ | 0.18 | 0.25 | 0.57 | 0.52 | |||||||||||||
From discontinued operations |
(2.09 | ) | (0.07 | ) | (3.81 | ) | 0.09 | |||||||||||
Net earnings (loss) |
(1.91 | ) | 0.18 | (3.24 | ) | 0.61 | ||||||||||||
Weighted average number of shares: |
||||||||||||||||||
Basic |
10,668 | 10,636 | 10,662 | 10,532 | ||||||||||||||
Diluted |
10,778 | 10,806 | 10,707 | 10,754 | ||||||||||||||
See accompanying notes to interim consolidated financial statements.
2
EMS Technologies, Inc.
Consolidated Balance Sheets (Unaudited)
(in thousands)
| Sep 27 | Dec 31 | |||||||||
| 2003 | 2002 | |||||||||
ASSETS |
||||||||||
Current assets: |
||||||||||
Cash and cash equivalents |
$ | 9,190 | 12,430 | |||||||
Trade accounts receivable |
69,354 | 71,719 | ||||||||
Inventories |
35,065 | 30,051 | ||||||||
Deferred income taxes |
1,693 | 1,693 | ||||||||
Assets held for sale |
44,257 | 77,128 | ||||||||
Total current assets |
159,559 | 193,021 | ||||||||
Property, plant and equipment: |
||||||||||
Land |
2,126 | 1,988 | ||||||||
Building and leasehold improvements |
15,012 | 14,835 | ||||||||
Machinery and equipment |
73,518 | 65,586 | ||||||||
Furniture and fixtures |
7,125 | 6,554 | ||||||||
Total property, plant and equipment |
97,781 | 88,963 | ||||||||
Less accumulated depreciation and amortization |
59,294 | 52,226 | ||||||||
Net property, plant and equipment |
38,487 | 36,737 | ||||||||
Deferred income taxes non-current |
1,740 | 1,780 | ||||||||
Accrued pension asset |
495 | 425 | ||||||||
Intangible assets, net |
3,114 | 3,499 | ||||||||
Goodwill, net |
13,526 | 13,526 | ||||||||
Prepaid
income taxes |
3,015 | | ||||||||
Other assets |
4,489 | 7,315 | ||||||||
| $ | 224,425 | 256,303 | ||||||||
See accompanying notes to interim consolidated financial statements.
3
EMS Technologies, Inc.
Consolidated Balance Sheets (Unaudited), continued
(in thousands, except share data)
| Sep 27 | Dec 31 | |||||||||
| 2003 | 2002 | |||||||||
LIABILITIES AND STOCKHOLDERS EQUITY |
||||||||||
Current liabilities: |
||||||||||
Current installments of long-term debt |
$ | 41,749 | 33,783 | |||||||
Accounts payable |
18,634 | 21,038 | ||||||||
Accrued compensation |
5,584 | 7,236 | ||||||||
Accrued retirement costs |
2,108 | 2,511 | ||||||||
Accrued post-retirement benefits |
560 | 443 | ||||||||
Deferred service revenue |
4,926 | 4,108 | ||||||||
Liabilities related to assets held for sale |
14,903 | 19,816 | ||||||||
Other liabilities |
2,404 | 2,624 | ||||||||
Total current liabilities |
90,868 | 91,559 | ||||||||
Long-term debt, excluding current installments |
15,880 | 18,759 | ||||||||
Total liabilities |
106,748 | 110,318 | ||||||||
Stockholders equity: |
||||||||||
Preferred stock of $1.00 par value per share.
Authorized 10,000,000 shares; none issued |
| | ||||||||
Common stock of $.10 par value per share.
Authorized 75,000,000 shares;
issued and outstanding 10,691,000 in 2003
and 10,658,000 in 2002 |
1,069 | 1,066 | ||||||||
Additional paid-in capital |
61,206 | 60,867 | ||||||||
Accumulated other comprehensive income (loss) |
168 | (5,821 | ) | |||||||
Retained earnings |
55,234 | 89,873 | ||||||||
Total stockholders equity |
117,677 | 145,985 | ||||||||
| $ | 224,425 | 256,303 | ||||||||
See accompanying notes to interim consolidated financial statements.
4
EMS Technologies, Inc.
Consolidated Statements of Cash Flows (Unaudited)
(in thousands)
| Nine Months Ended | ||||||||||||
| Sep 27 | Sep 28 | |||||||||||
| 2003 | 2002 | |||||||||||
Cash flows from operating activities: |
||||||||||||
Net earnings (loss) |
$ | (34,639 | ) | 6,569 | ||||||||
Adjustments to reconcile net earnings (loss) to net cash
provided by operating activities: |
||||||||||||
Depreciation and amortization |
6,620 | 5,636 | ||||||||||
Deferred income taxes |
40 | 1,274 | ||||||||||
Loss (income) from discontinued operations |
40,747 | (1,004 | ) | |||||||||
Changes in operating assets and liabilities: |
||||||||||||
Trade accounts receivable |
4,732 | (317 | ) | |||||||||
Inventories |
(3,182 | ) | 1,166 | |||||||||
Accounts payable |
(2,952 | ) | (773 | ) | ||||||||
Income taxes payable |
972 | 2,832 | ||||||||||
Accrued costs, deferred revenue and other current liabilities |
(1,912 | ) | (1,759 | ) | ||||||||
Other |
247 | (3,466 | ) | |||||||||
Net cash provided by operating activities |
10,673 | 10,158 | ||||||||||
Cash flows used in investing activities: |
||||||||||||
Purchase of property, plant and equipment |
(6,626 | ) | (6,590 | ) | ||||||||
Cash flows from financing activities: |
||||||||||||
Repayments of term debt |
(1,495 | ) | (1,663 | ) | ||||||||
Net increase in revolving debt |
4,138 | 1,974 | ||||||||||
Proceeds from exercise of stock options, net of withholding |
654 | 1,533 | ||||||||||
Net cash provided by financing activities |
3,297 | 1,844 | ||||||||||
Cash used by discontinued operations |
(10,779 | ) | (7,266 | ) | ||||||||
Net change in cash and cash equivalents |
(3,435 | ) | (1,854 | ) | ||||||||
Effect of exchange rates on cash |
195 | (597 | ) | |||||||||
Cash and cash equivalents at beginning of period |
12,430 | 11,777 | ||||||||||
Cash and cash equivalents at end of period |
$ | 9,190 | 9,326 | |||||||||
Supplemental disclosures of cash flow information: |
||||||||||||
Cash paid for interest |
$ | 2,587 | 2,840 | |||||||||
Cash paid for income taxes |
2,282 | 149 | ||||||||||
5
Non-Cash Investing and Financing:
In April 2002, the Company acquired Ottercom Ltd., a leading provider of Inmarsat communication terminals located in Tewkesbury, UK. Ottercom Ltd. products include critical components for EMS SATCOMs high-speed aeronautical data products. The company, now called EMS SATCOM UK, Ltd., operates as a unit of the Companys SATCOM segment. Management believes that this acquisition has helped strengthen the Companys presence in global mobile Internet/e-mail access and communications, and will enable the Company to continue to broaden its wireless product offerings and in-house development capability.
To accomplish this transaction, EMS issued 81,245 new shares of its common stock (valued at $1.9 million) and assumed liabilities totaling approximately $1.2 million. No goodwill was recognized in this transaction; rather, the $3.1 million total of net assets acquired was recorded as an intangible asset on the balance sheet. This intangible represents the value of Ottercom Ltd.s satellite communications technologies, intellectual property and product designs. This intangible will be amortized over an estimated useful life of 6 years.
See accompanying notes to interim consolidated financial statements.
6
EMS Technologies, Inc.
Notes to Interim Consolidated Financial Statements (Unaudited)
| 1. | Basis of Presentation |
| The interim consolidated financial statements include the accounts of EMS Technologies, Inc. and its wholly-owned subsidiaries LXE Inc. and EMS Technologies Canada, Ltd. (collectively, the Company). In the opinion of management, the interim consolidated financial statements reflect all normal and recurring adjustments necessary for a fair presentation of results for such periods. The results of operations for any interim period are not necessarily indicative of results for the full year. Certain prior period financial statement balances have been reclassified to conform to the current periods classification. These consolidated financial statements should be read in conjunction with the consolidated financial statements and related notes contained in the Companys Annual Report on Form 10-K for the year ended December 31, 2002. |
| In accordance with the provisions of Statement of Financial Accounting Standards (SFAS) No. 144, Accounting for the Impairment or Disposal of Long-Lived Assets, the Company has classified the revenues, expenses and related assets and liabilities of its Montreal space operations and its wireless networks healthcare operations, which are currently held for sale, as discontinued operations for all periods presented in the accompanying consolidated financial statements. |
| -- Stock Option Plans |
| Prior to January 1, 1996, the Company accounted for its stock option plans in accordance with the provisions of Accounting Principles Board (APB) Opinion No. 25, Accounting for Stock Issued to Employees, and related interpretations. As such, compensation expense would be recorded on the date of grant only if the current market price of the underlying stock exceeded the exercise price. On January 1, 1996, the Company adopted Statement of Financial Accounting Standards (SFAS) No. 123, Accounting for Stock-Based Compensation, which permits entities to recognize as expense, over the vesting period, the fair value of all stock-based awards on the date of grant. Alternatively, SFAS No. 123 also allows entities to continue to apply the provisions of APB Opinion No. 25 and provide pro forma net earnings and pro forma earnings per share disclosures for employee stock option grants made in 1995 and future years as if the fair-value-based method defined in SFAS No. 123 had been applied. The Company has elected to continue to apply the provisions of APB Opinion No. 25 and provide the pro forma disclosure required by SFAS No. 123. |
7
| The Company has adopted SFAS No. 148, Accounting for Stock-Based Compensation Transition and Disclosure, including the interim reporting requirements. The following table illustrates the effect on net earnings and earnings per share if the Company had applied the fair value method to measure stock-based compensation (in thousands, except net earnings per share): |
| Quarters Ended | Nine Months Ended | ||||||||||||||||
| Sep 27 | Sep 28 | Sep 27 | Sep 28 | ||||||||||||||
| 2003 | 2002 | 2003 | 2002 | ||||||||||||||
Net earnings (loss): |
|||||||||||||||||
As reported |
$ | (20,591 | ) | 1,966 | (34,639 | ) | 6,569 | ||||||||||
Less: Stock-based employee compensation
expense determined under the fair value
method, net of tax |
(475 | ) | (856 | ) | (1,753 | ) | (1,971 | ) | |||||||||
Pro forma |
$ | (21,066 | ) | 1,110 | (36,392 | ) | 4,598 | ||||||||||
Basic net earnings (loss) per share: |
|||||||||||||||||
As reported |
$ | (1.93 | ) | 0.18 | (3.25 | ) | 0.62 | ||||||||||
Pro forma |
(1.97 | ) | 0.10 | (3.41 | ) | 0.44 | |||||||||||
Diluted net earnings (loss) per share: |
|||||||||||||||||
As reported |
$ | (1.91 | ) | 0.18 | (3.24 | ) | 0.61 | ||||||||||
Pro forma |
(1.95 | ) | 0.10 | (3.40 | ) | 0.43 | |||||||||||
| 2. | Discontinued Operations |
| In the third quarter of 2003, EMS announced that its board of directors had approved a formal plan to sell the Companys commercial space division based in Montreal. Also during the third quarter of 2003, EMSs board of directors approved plans to dispose of the Companys Atlanta-based healthcare product line. As a result, these business components were accounted for as discontinued operations, and the net assets held for sale were written down to their estimated fair value upon disposal. The combined fair value adjustment was a $19 million pre-tax charge (comprising write-downs of $17 million related to assets associated with the Space & Technology/Montreal division and $2 million for the healthcare product line), with a related U.S. income tax benefit of approximately $2.9 million. The fair values upon disposal were estimated using discounted present value models. |
8
| The results of these discontinued operations for the third quarter and first nine months of 2003 and 2002 were as follows (in thousands): |
| Quarters Ended | Nine Months Ended | ||||||||||||||||
| Sep 27 | Sep 28 | Sep 27 | Sep 28 | ||||||||||||||
| 2003 | 2002 | 2003 | 2002 | ||||||||||||||
Net sales |
$ | 7,305 | 18,540 | 16,415 | 57,332 | ||||||||||||
Expense |
13,321 | 19,614 | |||||||||||||||